Neogen (NEOG) EBT Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neogen | 1.94 Bn | 1.78 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -26.74% |
| Nov 30, 2025 | -25.01% |
| Aug 31, 2025 | 17.20% |
| May 31, 2025 | -99.76% |
| Feb 28, 2025 | -21.80% |
| Nov 30, 2024 | -93.01% |
| Aug 31, 2024 | -23.60% |
| May 31, 2024 | -18.41% |
| Feb 29, 2024 | -18.64% |
| Nov 30, 2023 | -16.98% |
| Aug 31, 2023 | -37.28% |
| May 31, 2023 | -17.40% |
| Feb 28, 2023 | -16.33% |
| Nov 30, 2022 | -30.53% |
| Aug 31, 2022 | -17.32% |
| May 31, 2022 | -0.03% |
| Feb 28, 2022 | -15.83% |
| Nov 30, 2021 | -5.07% |
| Aug 31, 2021 | 7.36% |
| May 31, 2021 | 5.73% |
| Feb 28, 2021 | 6.54% |
| Nov 30, 2020 | 6.38% |
| Aug 31, 2020 | 6.53% |
| May 31, 2020 | 8.16% |
| Feb 29, 2020 | 4.14% |
| Nov 30, 2019 | 9.12% |
| Aug 31, 2019 | 5.19% |
| May 31, 2019 | 11.82% |
| Feb 28, 2019 | 10.15% |
| Nov 30, 2018 | 15.16% |
| Aug 31, 2018 | 7.57% |
| May 31, 2018 | 14.46% |
| Feb 28, 2018 | 11.43% |
| Nov 30, 2017 | 12.54% |
| Aug 31, 2017 | 10.63% |
| May 31, 2017 | 17.97% |
| Feb 28, 2017 | 14.13% |
| Nov 30, 2016 | 15.63% |
| Aug 31, 2016 | 10.34% |
| May 31, 2016 | 12.09% |
| Feb 29, 2016 | 8.21% |
| Nov 30, 2015 | 8.34% |
| Aug 31, 2015 | 9.38% |